Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Jul 19;13(7):1697.
doi: 10.3390/microorganisms13071697.

Global Epidemiology and Antimicrobial Resistance of Klebsiella Pneumoniae Carbapenemase (KPC)-Producing Gram-Negative Clinical Isolates: A Review

Affiliations
Review

Global Epidemiology and Antimicrobial Resistance of Klebsiella Pneumoniae Carbapenemase (KPC)-Producing Gram-Negative Clinical Isolates: A Review

Matthew E Falagas et al. Microorganisms. .

Abstract

Klebsiella pneumoniae carbapenemases (KPCs) are a group of class A β-lactamases of Gram-negative bacteria leading to difficult-to-treat infections. We evaluated the global epidemiology of KPC-producing Gram-negative clinical isolates. A systematic search of six databases (Cochrane Library, Embase, Google Scholar, PubMed, Scopus, and Web of Science) was conducted. Extracted data were tabulated and evaluated. After screening 1993 articles, 119 were included in the study. The included studies originated from Asia (n = 49), Europe (n = 29), North America (n = 14), South America (n = 11), and Africa (n = 3); 13 studies were multicontinental. The most commonly reported KPC-producing species were Klebsiella pneumoniae (96 studies) and Escherichia coli (52 studies), followed by Enterobacter cloacae (31), Citrobacter spp. (24), Klebsiella oxytoca (23), Serratia spp. (15), Enterobacter spp. (15), Acinetobacter baumannii complex (13), Providencia spp. (11), Morganella spp. (11), Klebsiella aerogenes (9), Pseudomonas aeruginosa (8), Raoultella spp. (8), Proteus spp. (8), and Enterobacter aerogenes (6). Among the studies with specific blaKPC gene detection, 52/57 (91%) reported the isolation of blaKPC-2 and 26/57 (46%) reported blaKPC-3. The antimicrobial resistance of the studied KPC-producing isolates was the lowest for ceftazidime-avibactam (0-4%). Resistance to polymyxins, tigecycline, and trimethoprim-sulfamethoxazole in the evaluated studies was 4-80%, 0-73%, and 5.6-100%, respectively. Conclusions: The findings presented in this work indicate that KPC-producing Gram-negative bacteria have spread globally across all continents. Implementing proper infection control measures, antimicrobial stewardship programs, and enhanced surveillance is crucial.

Keywords: Gram-negative; Klebsiella pneumoniae carbapenemase (KPC); global dissemination; global epidemiology; β-lactamase.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
a There were 5120 results in total but only the first 1000 results could be accessed with Google Scholar. * Consider, if feasible, reporting the number of records identified from each database or register searched (rather than the total number across all databases/registers). ** If automation tools were used, indicate how many records were excluded by a human and how many were excluded by automation tools.

Similar articles

References

    1. Lim C., Hantrakun V., Klaytong P., Rangsiwutisak C., Tangwangvivat R., Phiancharoen C., Doung-ngern P., Kripattanapong S., Hinjoy S., Yingyong T., et al. Frequency and Mortality Rate Following Antimicrobial-Resistant Bloodstream Infections in Tertiary-Care Hospitals Compared with Secondary-Care Hospitals. PLoS ONE. 2024;19:e0303132. doi: 10.1371/journal.pone.0303132. - DOI - PMC - PubMed
    1. Pulingam T., Parumasivam T., Gazzali A.M., Sulaiman A.M., Chee J.Y., Lakshmanan M., Chin C.F., Sudesh K. Antimicrobial Resistance: Prevalence, Economic Burden, Mechanisms of Resistance and Strategies to Overcome. Eur. J. Pharm. Sci. 2022;170:106103. doi: 10.1016/j.ejps.2021.106103. - DOI - PubMed
    1. Naghavi M., Vollset S.E., Ikuta K.S., Swetschinski L.R., Gray A.P., Wool E.E., Aguilar G.R., Mestrovic T., Smith G., Han C., et al. Global Burden of Bacterial Antimicrobial Resistance 1990–2021: A Systematic Analysis with Forecasts to 2050. Lancet. 2024;404:1199–1226. doi: 10.1016/S0140-6736(24)01867-1. - DOI - PMC - PubMed
    1. Babic M., Hujer A.M., Bonomo R.A. What’s New in Antibiotic Resistance? Focus on Beta-Lactamases. Drug Resist. Updates. 2006;9:142–156. doi: 10.1016/j.drup.2006.05.005. - DOI - PubMed
    1. Ambler R.P., Baddiley J., Abraham E.P. The Structure of β-Lactamases. Philos. Trans. R. Soc. Lond. B Biol. Sci. 1997;289:321–331. doi: 10.1098/rstb.1980.0049. - DOI - PubMed

LinkOut - more resources